☀️     🌓

Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

MeReC Extra 42

The National Prescribing Centre has published MeReC Extra 42 (PDF) which contains information about the risks and benefits of treating adults and children with oseltamivir for the treatment of influenza.

This MeReC Extra directs readers to the online patient decision aids made available earlier this year. Additional information is provided from recent trial work that aimed to assess the benefits of treatment in adults and in children.

Action: Clinicians who issue treatment for patients with symptoms of influenza will find this information useful and informative.

Share 'MeReC Extra 42' by emailShare 'MeReC Extra 42' on FacebookShare 'MeReC Extra 42' on TwitterShare 'MeReC Extra 42' on LinkedInShare 'MeReC Extra 42' on reddit


No Comments to “MeReC Extra 42”

Leave a Comment

Your email address will not be published. Required fields are marked *

Please be aware that you comment is subject to our Privacy Policy.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Connect to our RSS or Atom Feeds.